Evidence map›Paper›PMID 28828589›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2018

Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.

Pierpaolo Alongi, Laura Evangelista, Federico Caobelli, Marianna Spallino, Luigi Gianolli, Massimo Midiri, Maria Picchio

Abstract readEvaluation StudyMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 22 citations in OpenAlex.

  1. Nuclear medicine imaging in non-seminomatous germ cell tumors: lessons learned from the past failures.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Review
  2. Review
  3. Article
  4. [Scientific reports · 2023
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Pierpaolo AlongiNuclear Medicine Department, IRCSS San Raffaele Scientific Institute, Milan, Italy. alongi.pierpaolo@gmail.com.ORCID http://orcid.org/0000-0002-8397-1640
Laura EvangelistaNuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Federico CaobelliDepartment of Nuclear Medicine, Basel University Hospital, Basel, Switzerland.
Marianna SpallinoUniversity of Milano-Bicocca, 20126, Milan, Italy.
Luigi GianolliNuclear Medicine Department, IRCSS San Raffaele Scientific Institute, Milan, Italy.
Massimo MidiriDepartment of Radiological Sciences, Nuclear Medicine Unit, San Raffaele G.Giglio Institute, Contrada Pietrapollastra-Pisciotto, 90015, Cefalù, Italy.
Maria PicchioNuclear Medicine Department, IRCSS San Raffaele Scientific Institute, Milan, Italy.
Vita-Salute San Raffaele University · ITFondazione Istituto G. Giglio di Cefalù · ITIstituto Oncologico Veneto · ITUniversity Hospital of Basel · CHUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe aim of this bicentric retrospective study was to assess the diagnostic performance, the prognostic value, the incremental prognostic value and the impact on therapeutic management of MATERIALS AND

methodsFrom the databases of two centers including 31,500

resultsRecurrent GCT was confirmed in 47 of 52 patients with pathological

conclusion

Indexed as

AdultCarcinomaFluorodeoxyglucose F18HumansMaleMiddle AgedNeoplasm Recurrence, LocalPositron Emission Tomography Computed TomographyPredictive Value of TestsRadiopharmaceuticalsTesticular NeoplasmsFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG-PET/CTGerminal cell testicular carcinomaPrognostic roleRestagingTherapeutic management

Identifiers

PMID28828589
OpenAlexW2745823854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.